LONZA 04-418Q X-VIVO™ Chemically Defined, Serum-free Hematopoietic Cell Medium 研究背景 Lonza’s R&D efforts and collaboration with many clinical trials have provided Lonza with the tools and expertise to support the developments in adoptive immunotherapy, cancer therapy, genetic therapy and other cellular therapies. Lonza’s philosophy for the development of serum-free formulations for use in cellular therapy is to provide a nutritionally complete and balanced environment for the cells. We have not included any exogenous growth factors, artificial stimulators of cellular proliferation or undefined supplements. The products LONZA 04-418Q X-VIVO 15 are devoid of any protein-kinase C stimulators and are suitable for the investigation of second messenger systems in the activation of human and murine lymphocytes. The formulations are complete and contain pharmaceutical grade human albumin, recombinant human insulin and pasteurized human transferrin. All X-VIVO™ Medium products are manufactured under current GMPs and are listed with the FDA in a product Master File. Permission to cross-reference the Master File may be obtained by contacting the Product Manager.
LONZA X-VIVO™ 15 Chemically Defined, Serum-free Hematopoietic Cell Medium 簡(jiǎn)介 X-VIVO™ 20 Medium was developed and optimized to support the generation of LAK cells from monocyte-depleted PBL at high density. Initial cell densities between 2.0- 3.0 x 107 cells/ml were successfully used to generate LAK cells. X-VIVO™ Medium 20 may also be used as a growth medium for PBL and TIL.
X-VIVO™ 15 Chemically Defined, Serum-free Hematopoietic Cell Medium 使用注意事項(xiàng) 1. LONZA 04-418Q X-VIVO™ 15 is similar in composition to X-VIVO™ 10 and has been optimized for the proliferation of Tumor Infiltrating Lymphocytes (TIL) under serum-free conditions. 2.Please see Supplemental Information for additional hematopoietic cell applications. 3.X-VIVO™ 15, catalog number 04-418 is formulated with L-glutamine, gentamicin, and phenol red. Catalog number 04-744Q contains L-glutamine but does not contain gentamicin or phenol red. 4.X-VIVO™ 15, catalog number BE02-053Q is formulated with L-glutamine, gentamicin, recombinant transferrin, and phenol red. X-VIVO™ 15, catalog number BE02-054Q, contains L-glutamine and recombinant transferrin but does not contain gentamicin or phenol red. The recombinant transferrin replaces native transferrin.
Lonza X-VIVO™ 化學(xué)成分確定的無(wú)血清造血干細(xì)胞培養(yǎng)基訂購(gòu)信息 Catalog Number Description Size LONZA 04-380Q X-VIVO™ 10 Medium with L-glutamine, gentamicin, 1 L and phenol red LONZA 04-743Q X-VIVO™ 10 Medium with L-glutamine; without 1 L gentamicin or phen red LONZA BE04-418F X-VIVO™ 15 Medium with L-glutamine, gentamicin, 500ml and phenol red (Europe only) LONZA 04-418Q X-VIVO™ 15 Medium with L-glutamine, gentamicin, 1 L and phenol red 04-744Q X-VIVO™ 15 Medium with L-glutamine; without 1 L gentamicin orphenol red 04-448Q X-VIVO™ 20 Medium with L-glutamine, gentamicin, 1 L and phenol re
LONZA X-VIVO 15 無(wú)血清培養(yǎng)基英文簡(jiǎn)述: LONZA 04-418Q X-VIVO™ 15 is similar in composition to X-VIVO™ 10 and has been optimized for the proliferation of Tumor Infiltrating Lymphocytes (TIL) under serum-free conditions.
Please see Supplemental Information for additional hematopoietic cell applications.
LONZA X-VIVO™ 15, catalog number 04-418 is formulated with L-glutamine, gentamicin, and phenol red. Catalog number 04-744Q contains L-glutamine but does not contain gentamicin or phenol red.重慶市華雅干細(xì)胞技術(shù)有限公司在倉(cāng)庫(kù)備有現(xiàn)貨,歡迎新老客戶:
LONZA X-VIVO™ 15, catalog number BE02-053Q is formulated with L-glutamine, gentamicin, recombinant transferrin, and phenol red. X-VIVO™ 15, catalog number BE02-054Q, contains L-glutamine and recombinant transferrin but does not contain gentamicin or phenol red. The recombinant transferrin replaces native transferrin.
UltraCULTURE? Serum-free Medium英文簡(jiǎn)述: LONZA 12-725F UltraCULTURE? Serum-free Medium is a complete, allpurpose medium designed for the c*tion of a wide variety of adherent and non-adherent mammalian cell types. UltraCULTURE? Medium can be used to support fusion of cells during hybridoma formation, growth of monocyte, macrophage, epithelial, and fibroblastic cell lines, and generation of virus particles for vaccine production. The medium is supplemented with recombinant human insulin, bovine transferrin, and a purified mixture of bovine serum proteins. The total protein concentration of UltraCULTURE? Medium is approximay 3 mg/ml. UltraCULTURE? Medium can be supplemented with Cryoprotective Medium (Cat. No. 12-132A) to cryopreserve cells in a serum-free environment. UltraCULTURE? Medium does not contain L-glutamine; please add 5 ml of 200 mM L-glutamine solution (Cat. Nos. 17-605 or 17-905) prior to use.
The formulation for UltraCULTURE? Medium has been submitted to the FDA as a Master File. Permission to crossreference the Master File may be obtained by contacting the Regulatory Affairs Department.
Applications – C*tion of adherent and non-adherent mammalian cells – Generation of viral particles for vaccine production Performance and Quality Tests – Turbidity may develop in UltraCULTURE? Medium; experiments have determined that the turbidity will not alter the performance of the product